未登录

R

Rosanna Sestito

IRCCS

H指数:18

被引数:975

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nuclear gasdermin E drives endothelin-1-induced metastatic progression independently of the pyroptosis

核Gasdermin E独立于焦亡，驱动内皮素-1诱导的转移性进展。

Cell Death & Disease

IF9.6

2026-01-160

OAAI

DNA damaging agents boost the transcription of endothelin A receptor in high-grade serous ovarian cancer

DNA损伤剂增强了高级别浆液性卵巢癌中内皮素A受体的转录。

Journal of Experimental & Clinical Cancer Research

IF12.8

2025-12-060

OAAI

Circulating miR-18b-3p is a novel biomarker predicting chemo-radiotherapy induced oral mucositis in head and neck cancer

循环miR-18b-3p是预测头颈癌放化疗诱导性口腔黏膜炎的新型生物标志物

Signal Transduction and Targeted Therapy

IF52.7

2025-11-210

OAAI

Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer [Matrix Biol. 81 (2019) 17-33]

通过内皮素-1受体信号通路，IQGAP1对卵巢癌中细胞外基质降解和转移扩散的调控 [Matrix Biol. 81 (2019) 17-33]

IF4.8

2025-02-010

OAAI

YAP signaling orchestrates the endothelin-1-guided invadopodia formation in high-grade serous ovarian cancer

BIOSCIENCE REPORTS

IF4.7

2024-11-290

OAAI

Endothelin-1 receptor blockade impairs invasion patterns in engineered 3D high-grade serous ovarian cancer tumouroids

CLINICAL SCIENCE

IF7.7

2024-11-150

OAAI

The endothelin-1-driven tumor-stroma feed-forward loops in high-grade serous ovarian cancer

CLINICAL SCIENCE

IF7.7

2024-07-050

OAAI

The new world of RNA diagnostics and therapeutics

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-07-292

OAAI

Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition

CELL DEATH & DISEASE

IF9.6

2023-01-0516

OAAI

Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2022-04-286

OAAI

Endothelin-1 drives invadopodia and cross-talk with submesothelial matrix invasion cell through ILK

CANCER RESEARCH

IF16.6

2021-03-010

PRE

Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK

IF6.9

2021-03-0121

OAAI

Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer

COMMUNICATIONS BIOLOGY

IF5.1

2020-11-1317

OAAI

Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer

IF10.1

2020-11-0116

OAAI

Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer

CELL DEATH AND DIFFERENTIATION

IF15.4

2017-07-1439

OAAI

Endothelin-1 receptor/β-arrestin1 is an actionable node that regulates YAP/TAZ signaling and chemoresistance in high-grade ovarian cancer

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis

IF5.1

2016-08-0117

PREAI

Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer

IF5.1

2016-08-0114

PREAI

Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma

IF7.3

2015-11-0249

OAAI